Skip to content

The Efficacy of Adductor-Canal-Blockade on Morphine Consumption, Pain and Mobilisation After Total Knee Arthroplasty

The Efficacy of Adductor-Canal-Blockade on Morphine Consumption, Pain and Mobilisation After Total Knee Arthroplasty

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01104883
Enrollment
70
Registered
2010-04-16
Start date
2010-08-31
Completion date
2011-03-31
Last updated
2011-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Arthroplasty

Keywords

Adductor-Canal-Blockade, postoperative pain, US-guided nerve block, total knee arthroplasty

Brief summary

The purpose of this study is to determine whether Adductor-Canal-Blockade is effective at reducing morphine consumption and pain, and at the same time improving mobilisation after total knee arthroplasty.

Interventions

US-guided Adductor-Canal-Blockade with ropivacaine 7,5 mg/ml

US-guided Adductor-Canal-blockade with saline

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Total Knee Arthroplasty in spinal anaesthesia * ASA 1-3 * BMI 18-40 * Written informed consent

Exclusion criteria

* Can not cooperate to the exam * Do not speak or understand Danish * Drug allergy * Alcohol or drug abuse * Daily consumption of strong opioids * Unable to complete the Timed Up and Go test preoperatively

Design outcomes

Primary

MeasureTime frameDescription
Total morphine consumption0-24 hours postoperativeTotal morphine consumption at the interval 0-24 hours postoperative.

Secondary

MeasureTime frameDescription
Pain during rest0-26 hours postoperative0-100 mm at a visual analogue scale (VAS), at the intervals 2, 4, 8, 24 and 26 hours postoperative, and the area under the curve for the intervals 2-24 and 24-26 hours postoperative.
Pain during 45 degrees active flexion of the knee0-26 hours postoperative0-100 mm at a visual analogue scale (VAS), at the intervals 2, 4, 8, 24 and 26 hours postoperative, and the area under the curve for the intervals 2-24 and 24-26 hours postoperative.
A change in pain in the placebo group24-26 hours postoperative0-100 mm at a visual analogue scale (VAS), at the intervals 24 and 26 hours postoperative.
Postoperative nausea0-26 hours postoperativeNausea scores(0-3)at 2,4,8,24,26 hours postoperative.
Total morphine consumption0-26 hours postoperativeTotal morphine consumption at the intervals 0-2, 0-4, 0-8 and 0-26 hours postoperative.
Sedation0-26 hours postoperativeSeadtion score (0-3) at 2,4,8,24,26 hours postoperative.
Mobilisation20-26 hours postoperativeNumber of seconds it takes to complete the Timed Up and Go test, at 20 and 26 hours postoperative.
Postoperative vomiting0-26 hours postoperativeNumber of vomiting episodes at the intervals 0-2,2-4,4-8,8-24,24-26 hours postoperative.
Zofran consumption0-26 hours postoperativeTotal zofran consumption at the intervals 0-24 and 24-26 hours postoperative.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026